Survival in Patients With Idiopathic, Familial, and Anorexigen-Associated Pulmonary Arterial Hypertension in the Modern Management Era

By M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib, V. Gressin, A. Yaïci, E. Weitzenblum, J. Cordier, F. Chabot and 12 more. Circulation, 2010

1,409 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Molecular Biology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/32aa8d6142210563c7ecda91d4d5572498ceb026

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Pulmonary and Respiratory Medicine

1. G. Simonneau
2. N. Galiè

Citations in the corpus

• Updated clinical classification of pulmonary hypertension. (2009, background): “The 1-year mortality rate in patients with idiopathic PAH is approximately 15% (31) versus 30% in PAH-associated with scleroderma (32).”
• Initial Use of Ambrisentan plus Tadalafil in Pulmonary Arterial Hypertension. (2015, background): “Disease progression 10 (4) 16 (6) 12 (10) 4 (3)”